[go: up one dir, main page]

NO20075592L - Antistoffer og beslektede molekyler som bindes til PSCA Proteiner - Google Patents

Antistoffer og beslektede molekyler som bindes til PSCA Proteiner

Info

Publication number
NO20075592L
NO20075592L NO20075592A NO20075592A NO20075592L NO 20075592 L NO20075592 L NO 20075592L NO 20075592 A NO20075592 A NO 20075592A NO 20075592 A NO20075592 A NO 20075592A NO 20075592 L NO20075592 L NO 20075592L
Authority
NO
Norway
Prior art keywords
psca
antibodies
bind
variants
fragment
Prior art date
Application number
NO20075592A
Other languages
English (en)
Other versions
NO345322B1 (no
Inventor
Aya Jakobovits
Arthur B Raitano
Pia M Challita-Eid
Xiao-Chi Jia
Robert Kendall Morrison
Jean Gudas
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/017412 external-priority patent/WO2005118864A2/en
Priority claimed from US11/131,648 external-priority patent/US7595379B2/en
Priority claimed from PCT/US2006/005693 external-priority patent/WO2006112933A1/en
Application filed by Agensys Inc filed Critical Agensys Inc
Publication of NO20075592L publication Critical patent/NO20075592L/no
Publication of NO345322B1 publication Critical patent/NO345322B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SAMMENDRAG Antistoffer og molekyler avledet derfra som binder til nytt PSCA-protein og varianter derav, er beskrevet hvor PSCA oppviser vevsspesifikk ekspresjon i normalt voksent vev og blir avvikende uttrykt i kreftformen listet opp i Tabell I. Følgelig tilveiebringer PSCA et diagnostisk, prognostisk, profylaktisk og/eller terapeutisk mål for kreft. PSCA-genet eller fragment derav eller dets kodede protein eller varianter derav eller et fragment derav, kan anvendes for å fremkalle en humoral eller cellulær immunrespons; antistoffer eller T-celler reaktive med PSCA kan anvendes ved aktiv eller passiv immunisering.
NO20075592A 2005-04-14 2007-11-05 Antistoffer og beslektede molekyler som bindes til PSCA Proteiner NO345322B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67200005P 2005-04-14 2005-04-14
PCT/US2005/017412 WO2005118864A2 (en) 2004-05-28 2005-05-17 Antibodies and related molecules that bind to psca proteins
US11/131,648 US7595379B2 (en) 2003-05-30 2005-05-17 Antibodies and related molecules that bind to PSCA proteins
PCT/US2006/005693 WO2006112933A1 (en) 2005-04-14 2006-02-15 Antibodies and related molecules that bind to psca proteins

Publications (2)

Publication Number Publication Date
NO20075592L true NO20075592L (no) 2008-01-11
NO345322B1 NO345322B1 (no) 2020-12-07

Family

ID=39226555

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075592A NO345322B1 (no) 2005-04-14 2007-11-05 Antistoffer og beslektede molekyler som bindes til PSCA Proteiner

Country Status (2)

Country Link
CN (1) CN101223191B (no)
NO (1) NO345322B1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113423822A (zh) * 2018-12-13 2021-09-21 贝里坤制药股份有限公司 Psca car-t细胞
CN119930826A (zh) * 2023-11-02 2025-05-06 重庆精准生物产业技术研究院有限公司 针对psca的全人源单链抗体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541212B2 (en) * 1997-03-10 2003-04-01 The Regents Of The University Of California Methods for detecting prostate stem cell antigen protein
EP1514876B1 (en) * 1997-03-10 2013-05-08 The Regents of The University of California Antibody against prostate stem cell antigen (PSCA)
DK1226177T3 (da) * 1999-10-29 2008-10-06 Genentech Inc Antistofsammensætninger mod anti-prostata stamcelle-antigen (PSCA) og anvendelser deraf
ATE541052T1 (de) * 2003-05-30 2012-01-15 Agensys Inc Varianten des prostata-stammzellen-antigens (psca) und teilsequenzen davon

Also Published As

Publication number Publication date
CN101223191A (zh) 2008-07-16
NO345322B1 (no) 2020-12-07
CN101223191B (zh) 2012-09-05

Similar Documents

Publication Publication Date Title
NO20075103L (no) Antistoffer og relaterte molekyler som bindes til 161P2F10B proteiner
NO20065366L (no) Antistoffer og molekyler som er avledet fra disse som binder til STEAP-1-proteiner
NO20055508L (no) Prostata stamcelleantigen (PSCA) varianter og subsekvenser derav
WO2009033094A3 (en) Antibodies and related molecules that bind to 24p4c12 proteins
BRPI0606790A2 (pt) anticorpo humano isolado ou porção de ligação de antìgeno do mesmo, polipeptìdeo isolado, composição, ácido nucleico isolado, vetor de expressão célula hospedeira, vacina contra a raiva, kit, uso de um anticorpo monoclonal humano isolado ou porção de ligação de antìgeno do mesmo, ou de uma quantidade eficaz de uma composição, método para identificar um anticorpo ou um fragmento do mesmo, anticorpo ou fragmento do mesmo, anticorpo ou fragmento do mesmo,e, glicoproteìna.
ATE537188T1 (de) Serumalbuminbindende proteine
CL2014001293A1 (es) Anticuerpo monocional o fragmento enlazante a antigeno del mismo, especifico para proteinas de citomegalovirus humano (hcmv); molecula de acido nucleico que lo codifica; celula huesped; metodo de produccion; composicion que lo comprende; y su uso para el tratamiento de infeccion por hcmv (div sol 84-2011)
BRPI0510475A (pt) adenovìrus quimérico para o uso no tratamento de cáncer
NO20065874L (no) Antistoffer og beslektede molekyler som bindes til PSCA proteiner
IL181218A0 (en) Nucleic acids and corresponding 58p1d12 proteins for use in the detection and treatment of cancer
CL2011003273A1 (es) Antígeno del virus respiratorio sincicial (vrs) recombinante, que comprende un polipéptido de proteína f soluble con una modificación que altera su glicosilación y que a su vez comprende un dominio f1 y un dominio f2 de proteína f de vrs; composición inmunogénica que lo comprende; ácido nucleico que lo codifica; vector; célula hospedera; método para producir dicho antígeno del vrs; y su uso para tratar una infección de vrs.
IL187321A0 (en) Host cell specific binding molecules capable of neutralizing viruses and uses thereof
CN115943162A (zh) 抗Claudin18.2抗体以及其用途
NO20083062L (no) Humane monoklonale antistoffer mot fukosyl-GM1 og fremgangsmater for anvendelse av anti-fukosyl-GM1
BRPI0619595A8 (pt) anticorpo neutralizante, epítopo, seqüência de dna isolada, vetor de clonagem ou expressão, célula hospedeira, processo para a produção de um anticorpo, composição farmacêutica, e, uso de um anticorpo neutralizante humanizado ou completamente humano
DK2054431T3 (da) Konformere af bakterielle adhæsiner
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
NO20075592L (no) Antistoffer og beslektede molekyler som bindes til PSCA Proteiner
WO2007075915A3 (en) Monoclonal antibodies against orthopoxviruses
EA200970332A1 (ru) Новые антигены и антитела, ассоциированные с аденокарциномой панкреатического протока
NO20052714L (no) Fremgangsmater og materialer for behandling av inflammatoriske tilstander
NO20065651L (no) Spesifikke bindingsmedlemmer
WO2004029276A3 (en) Nucleic acids encoding a mammalian raptor polypeptide and uses therefor
CY1112424T1 (el) Πυρηνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 238ρ1β2 χρησιμα στην αγωγη και ανιχνευση του καρκινου
WO2002095009A3 (en) Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer